Osteoprotegerin (OPG) Aoki K, et al. Peptide-based delivery to bone. Adv Drug Deliv Rev. 2012 Sep;64(12):1220-38. Yamaguchi K, et al. Characterization of structural domains of human osteoclastogenesis inhibitory factor. J Biol Chem. 1998 Feb 27;273(9):5117-23. Rowinsky EK. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis- inducing ligand receptor activating agents. J Clin Oncol. 2005 Dec 20;23(36):9394-407.
36
Embed
Deciphering the role of osteoprotegerin in inflammatory bowel diseases
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Osteoprotegerin (OPG)
Aoki K, et al. Peptide-based delivery to bone. Adv Drug Deliv Rev. 2012 Sep;64(12):1220-38.
Yamaguchi K, et al. Characterization of structural domains of human osteoclastogenesis inhibitory factor. J Biol Chem. 1998 Feb 27;273(9):5117-23.
Rowinsky EK. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol. 2005 Dec 20;23(36):9394-407.
RANKL-RANK Pathway
Chung PY and Van Hul W. Paget's disease of bone: evidence for complex pathogenetic interactions. Semin Arthritis Rheum. 2012 Apr;41(5):619-41.
RANK-RANKL-OPG interaction
Nelson CA, et al. RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor. Structure. 2012 Nov 7;20(11):1971-82.
OPG as an effector molecule
Theoleyre S, et al. Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK. Biochim Biophys Acta. 2004 Feb 2;1644(1):1-7.
Theoleyre S, et al. Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK. Biochim Biophys Acta. 2004 Feb 2;1644(1):1-7.
Heparan sulfate related proteoglycans
Observations made in our lab
1) Increased levels of OPG in feces of children suffering from inflammatory bowel diseases (IBD) compared to non-IBD
2) Colon biopsy (organ) cultures from patients with IBD secreted significantly more OPG when compared to non-IBD
3) Secretion of OPG by Lamina propria mononuclear cell cultures from patients with IBD and non-IBD were not significantly different
4) Immunohistochemical staining for OPG in sections of colon biopsies from patients with IBD showed specific signal in goblet cell mucus
5) Nuclear OPG signal was seen only in intestinal epithelial cells of colon biopsies from patients with out IBD
cont.
Observations made in our lab – cont.
6) Immunofluorescence staining for OPG in colorectal carcinoma cell lines (Caco-2, T84 and HCT116)
7) Nuclear OPG signal was seen in Caco-2 cells8) Osteoprotegerin in the nuclear extract of Caco-2 cells could
be demonstrated by Western blot and ELISA 9) Treatment of Caco-2 cells with tumor necrosis factor-α (TNF-
α) and interleukin-1β (IL-1β) but not lipopolysaccharide lead to significantly increased secretion of OPG
10) Treatment of Caco-2 cells with IL-18 does not lead to increased secretion of OPG
Immunohistochemical staining of colonic biopsy for OPG
Non
-IBD
Non
-IBD
Anti-OPG Isotype
N = 5
Immunohistochemical staining of colonic biopsy for OPG
Anti-OPG Isotype
New
IBD
IBD
in re
miss
ion
N = 5
Granular pattern
OPG signal in goblet cells of colon biopsy of IBD patients
N = 3
Colon biopsy of IBD patient
Goblet cell signal
Colon biopsies – IHC staining with isotype for anti-OPG antibody (IMG103A) with out counterstaining
Colon biopsies – IHC staining for OPG with out counterstaining
Non-IBD
IBD in remission New IBD N = 3
Crypt lumen
Goblet cells
Nuclei of intestinal epithelial cells
Crypt lumenNuclei of intestinal epithelial cells
Colon biopsies – IHC staining for OPG with out counterstaining
N = 3Non-IBD
Crypt lumenNuclei of intestinal epithelial cells
New IBD
Colon biopsies – IHC staining for OPG with out counterstaining
N = 3
T84 Caco2 HCT116 MG63
OPG
DAPI/ OPG
DAPI/ OPGIsotype
Immunocytochemical staining of cell lines
N = 5
Immunofluorescence staining for OPG: Caco-2 cells
OPGDAPI
N = 8
Confocal microscopy of Caco-2 cells stained for OPG
Confocal microscopy of Caco-2 cells stained for OPG